[Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections]. 1985

H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1992, The Journal of international medical research,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1989, APMIS. Supplementum,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
February 1991, The Japanese journal of antibiotics,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1981, Reviews of infectious diseases,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
September 2001, International journal of antimicrobial agents,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1977, The Journal of international medical research,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
July 1990, Hinyokika kiyo. Acta urologica Japonica,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1986, The Journal of international medical research,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1979, Giornale italiano di chemioterapia,
H Kobayashi, and K Takamura, and K Kono, and T Nihei, and A Saito, and I Nakayama, and A Ujiie, and O Yajima, and M Tango, and M Tomizawa
January 1989, APMIS. Supplementum,
Copied contents to your clipboard!